{
    "clinical_study": {
        "@rank": "79141", 
        "brief_summary": {
            "textblock": "To compare the safety and tolerance of oral ganciclovir at a double dose 3 times/day or a\n      single dose 6 times/day to IV ganciclovir given for 20 weeks of maintenance therapy. To\n      compare the time to progression of cytomegalovirus (CMV) retinitis between two regimens of\n      oral ganciclovir and IV ganciclovir therapy given for 20 weeks of maintenance therapy. To\n      describe the efficacy and safety of double dose versus single dose oral ganciclovir in\n      patients who have a progression of retinitis while on the originally assigned maintenance\n      treatment. To describe the safety, tolerance, and time to progression of retinitis during\n      the 52 weeks of oral ganciclovir maintenance therapy in people with AIDS. To describe the\n      safety and tolerance of oral ganciclovir maintenance therapy when given concurrently with\n      antiretroviral treatment (e.g., zidovudine, ddI, or ddC). To describe survival of people\n      with AIDS and CMV retinitis."
        }, 
        "brief_title": "A Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir Therapy", 
        "condition": [
            "Cytomegalovirus Retinitis", 
            "HIV Infections"
        ], 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome", 
                "Retinitis", 
                "Cytomegalovirus Retinitis"
            ]
        }, 
        "detailed_description": {
            "textblock": "Two hundred twenty-five patients with AIDS and CMV retinitis are eligible for enrollment in\n      Groups A, B, and C of the study, provided that each subject has received and tolerated a\n      therapeutic course of intravenous (IV) ganciclovir of at least 4 weeks duration resulting in\n      stable retinitis. An additional 100 subjects who have received and tolerated a course of IV\n      or oral ganciclovir under any clinical trial of oral ganciclovir sponsored by Syntex\n      Research and have stable retinitis may enter into Group D of this study and receive oral\n      ganciclovir."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Concurrent Medication:\n\n        Allowed:\n\n          -  Zidovudine except during the first 2 weeks of any oral or IV ganciclovir maintenance\n             therapy.\n\n          -  ddI.\n\n          -  ddC.\n\n        Patients must have:\n\n          -  Confirmed HIV infection or diagnosis of AIDS.\n\n          -  CMV retinitis of no more than 4 months duration.\n\n          -  Stable retinitis.\n\n          -  Understanding of the nature of the study, agree to its provisions, and sign informed\n             consent.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following symptoms and conditions are excluded:\n\n          -  Persistent or clinically significant diarrhea (3 or more unformed stools/day),\n             nausea, or abdominal pain or other gastrointestinal symptoms or uncontrolled\n             gastrointestinal disease.\n\n          -  Ocular media opacities (corneal, lenticular, or vitreal) preventing ophthalmologic\n             retinal assessment.\n\n          -  Ocular conditions requiring immediate surgical correction (e.g., retinal tear or\n             detachment).\n\n          -  Dementia, decreased mentation, or other encephalopathic signs and symptoms that would\n             interfere with the ability of the subject to give informed consent or comply with the\n             protocol.\n\n        Concurrent Medication:\n\n        Excluded:\n\n          -  Zidovudine during the first 2 weeks of any oral or IV ganciclovir maintenance\n             therapy.\n\n          -  Antimetabolites.\n\n          -  Alkylating agents.\n\n          -  Selected nucleoside analogs.\n\n          -  Selected cytokines.\n\n        Patients with the following prior conditions are excluded:\n\n          -  Diagnosis of CMV retinitis more than 4 months prior to study entry.\n\n          -  More than two prior induction treatments of IV ganciclovir (initial induction and one\n             re-induction are permitted).\n\n        Prior Medication:\n\n        Excluded:\n\n          -  More than two induction treatment regimens with IV ganciclovir.\n\n          -  Prior oral ganciclovir (in Groups A, B, and C only)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "13 Years"
        }, 
        "enrollment": "225", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002247", 
            "org_study_id": "059C", 
            "secondary_id": "ICM 1774"
        }, 
        "intervention": {
            "intervention_name": "Ganciclovir", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Ganciclovir"
        }, 
        "keyword": [
            "Retinitis", 
            "Ganciclovir", 
            "Cytomegalovirus Infections", 
            "Administration, Oral", 
            "Acquired Immunodeficiency Syndrome"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Berkeley", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94704"
                    }, 
                    "name": "East Bay AIDS Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "900951793"
                    }, 
                    "name": "AIDS Clinical Research Ctr / UCLA Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92103"
                    }, 
                    "name": "UCSD Med Ctr / Pediatrics"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "941102859"
                    }, 
                    "name": "San Francisco Gen Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94115"
                    }, 
                    "name": "Mount Zion Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94114"
                    }, 
                    "name": "Davies Med Ctr / c/o HIV Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94118"
                    }, 
                    "name": "Dr David Busch"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20007"
                    }, 
                    "name": "Georgetown Univ Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33125"
                    }, 
                    "name": "Miami Veterans Administration Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30308"
                    }, 
                    "name": "AIDS Research Consortium of Atlanta"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Honolulu", 
                        "country": "United States", 
                        "state": "Hawaii", 
                        "zip": "96816"
                    }, 
                    "name": "Margo Heath - Chiozzi"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60612"
                    }, 
                    "name": "Rush Presbyterian - Saint Luke's Med Ctr / Rush Med Coll"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02215"
                    }, 
                    "name": "Beth Israel Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10016"
                    }, 
                    "name": "Dr Dorothy Friedberg"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10021"
                    }, 
                    "name": "Cornell Univ Med College"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19107"
                    }, 
                    "name": "Buckley Braffman Stern Med Associates"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75219"
                    }, 
                    "name": "Oak Lawn Physicians Group"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Galveston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77550"
                    }, 
                    "name": "Univ TX Galveston Med Branch"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98144"
                    }, 
                    "name": "Univ of Washington / Pacific Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vancouver", 
                        "country": "Canada", 
                        "state": "British Columbia"
                    }, 
                    "name": "Saint Paul's Hosp"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Canada"
            ]
        }, 
        "official_title": "A Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir Therapy", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "reference": {
            "PMID": "9110064", 
            "citation": "Danner SA, Matheron S. Cytomegalovirus retinitis in AIDS patients: a comparative study of intravenous and oral ganciclovir as maintenance therapy. AIDS. 1996 Dec;10 Suppl 4:S7-11."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002247"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hoffmann-La Roche", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety Study, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 1993"
    }, 
    "geocoordinates": {
        "AIDS Clinical Research Ctr / UCLA Med Ctr": "34.052 -118.244", 
        "AIDS Research Consortium of Atlanta": "33.749 -84.388", 
        "Beth Israel Hosp": "42.358 -71.06", 
        "Buckley Braffman Stern Med Associates": "39.952 -75.164", 
        "Cornell Univ Med College": "40.714 -74.006", 
        "Davies Med Ctr / c/o HIV Institute": "37.775 -122.419", 
        "Dr David Busch": "37.775 -122.419", 
        "Dr Dorothy Friedberg": "40.714 -74.006", 
        "East Bay AIDS Ctr": "37.872 -122.273", 
        "Georgetown Univ Med Ctr": "38.895 -77.036", 
        "Margo Heath - Chiozzi": "21.307 -157.858", 
        "Miami Veterans Administration Med Ctr": "25.789 -80.226", 
        "Mount Zion Med Ctr": "37.775 -122.419", 
        "Oak Lawn Physicians Group": "32.803 -96.77", 
        "Rush Presbyterian - Saint Luke's Med Ctr / Rush Med Coll": "41.878 -87.63", 
        "Saint Paul's Hosp": "49.261 -123.114", 
        "San Francisco Gen Hosp": "37.775 -122.419", 
        "UCSD Med Ctr / Pediatrics": "32.715 -117.157", 
        "Univ TX Galveston Med Branch": "29.301 -94.798", 
        "Univ of Washington / Pacific Med Ctr": "47.606 -122.332"
    }
}